Renal functional reserve in obesity hypertension

被引:33
作者
Pecly, I. M. D. [1 ]
Genelhu, V. [1 ]
Francischetti, E. A. [1 ]
机构
[1] Univ Estado Rio De Janeiro, Hypertens Clin CLINEX, BR-20511010 Rio De Janeiro, Brazil
关键词
hypertension; kinins; nitric oxide; obesity; renal reserve;
D O I
10.1111/j.1742-1241.2006.01037.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The capacity to increase glomerular filtration rate in response to an acute oral protein load is known as the renal functional reserve; the loss of such capacity is used as a marker of hyperfiltration. This physiological response in obese hypertensives is not yet fully understood. We aimed to study the interdependent effects of obesity and hypertension on renal reserve, taking into account renal kallikrein and nitric oxide in the modulation of that parameter. Fourteen obese hypertensives (mean age, 50.5 +/- 0.9 years) and nine lean hypertensives (mean age, 50.6 +/- 2.7 years) were evaluated. Renal haemodynamics and the levels of serum nitric oxide and urinary kallikrein were assessed at baseline and after a protein load (1 g/kg of body weight). An increase in the following parameters was observed when comparing obese and lean hypertensives: basal glomerular filtration rate; renal plasma flow; and urinary kallikrein and nitric oxide levels (129.2 +/- 2.9 vs. 101.4 +/- 3.4 ml/min/1.73 m(2); 587.5 +/- 18.2 vs. 502.8 +/- 16.7 ml/min/1.73 m(2); 0.120 +/- 0.02 vs. 0.113 +/- 0.02 mU/ml; 23.2 +/- 0.8 vs. 19.5 +/- 1.2 mmol/ml, respectively). The renal reserve was lower in obese hypertensives when compared with that of lean hypertensives (4.1 +/- 0.5 vs. 11.8 +/- 0.8 ml/min, p < 0.005). After a protein load, contrasting with the lean group, inability to elevate the nitric oxide serum levels and a lower increase in urinary kallikrein were observed in the obese group. These data suggest that obese hypertensives lose renal reserve earlier in the evolution to renal dysfunction. This may be due to the defective modulation of renal vasodilatation mechanisms by renal kallikrein and nitric oxide production.
引用
收藏
页码:1198 / 1203
页数:6
相关论文
共 41 条
[31]   COMBINED RENAL EFFECTS OF OVERWEIGHT AND HYPERTENSION [J].
RIBSTEIN, J ;
DUCAILAR, G ;
MIMRAN, A .
HYPERTENSION, 1995, 26 (04) :610-615
[32]  
RUSSELL CD, 1989, J NUCL MED, V30, P2053
[33]   Renal function reserve and sodium sensitivity in essential hypertension [J].
Sanai, T ;
Kimura, G .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1996, 128 (01) :89-97
[34]  
SCHNURR E, 1980, CLIN NEPHROL, V13, P26
[35]   Bradykinin B-2 receptor modulates renal prostaglandin E(2) and nitric oxide [J].
Siragy, HM ;
Jaffa, AA ;
Margolius, HS .
HYPERTENSION, 1997, 29 (03) :757-762
[36]   WEIGHT AND BLOOD-PRESSURE FINDINGS IN HYPERTENSION SCREENING OF 1-MILLION AMERICANS [J].
STAMLER, R ;
STAMLER, J ;
RIEDLINGER, WF ;
ALGERA, G ;
ROBERTS, RH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1978, 240 (15) :1607-1610
[37]   Obesity/insulin resistance is associated with endothelial dysfunction - Implications for the syndrome of insulin resistance [J].
Steinberg, HO ;
Chaker, H ;
Leaming, R ;
Johnson, A ;
Brechtel, G ;
Baron, AD .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (11) :2601-2610
[38]  
TAUXE WN, 1984, RENOVASCULAR HYPERTE, P114
[39]  
WHITE RP, 1954, J LAB CLIN MED, V43, P475
[40]   MODULATION OF THE VASODEPRESSOR ACTIONS OF ACETYLCHOLINE, BRADYKININ, SUBSTANCE-P AND ENDOTHELIN IN THE RAT BY A SPECIFIC INHIBITOR OF NITRIC-OXIDE FORMATION [J].
WHITTLE, BJR ;
LOPEZBELMONTE, J ;
REES, DD .
BRITISH JOURNAL OF PHARMACOLOGY, 1989, 98 (02) :646-652